NOVO-B · Novo Nordisk A S · Debt

255.2500 DKK +5.3500 (+2.14%) At close · Oct 9

Financials

Earnings & Events

Ownership

Short & Settlement

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Bonds issued	2025-12-31	DKK 121,074,000,000	20-F filed 2026-02-04
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current bonds issued, including current portion of noncurrent bonds DKK 9,701,000,000 Noncurrent bonds issued DKK 111,373,000,000
Borrowings	2025-12-31	DKK 130,958,000,000	20-F filed 2026-02-04
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current portion of long-term borrowings DKK 12,017,000,000 Noncurrent long-term borrowings DKK 118,941,000,000 Short-term borrowings DKK 12,017,000,000
Borrowings	2025-12-31	EUR 10,000,000,000	20-F filed 2026-02-04
Lease liabilities	2025-12-31	DKK 8,572,000,000	20-F filed 2026-02-04
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current lease liabilities DKK 1,336,000,000 Noncurrent lease liabilities DKK 7,236,000,000

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.